Secondary Haemophagocytic Lymphohistiocytosis – The Differential Diagnosis Dilemma In Paediatrics

1. Lipton JM, Arceci RJ. Histiocytic disorders. In: Hoffman R, Edward B, eds. Hematology: basic principles and practice. 4^th ed. Philadelphia: Churchill Livingstone. 2005; 857–67.Search in Google Scholar

2. Ladisch S. Histiocytosis syndrome in childhood. In: Behrman ER, Kliegman MR, Jenson BH. NELSON Textbook of pediatrics, vol 2, 17th ed. Belgrade: Saunders, Bard 2009; 1727–30. (translated)Search in Google Scholar

3. Favara BE, Feller AC, Pauli M et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol. 1997; 29(3): 157–66.10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-CSearch in Google Scholar

4. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006; 38(1): 20–31.10.1080/07853890500465189Search in Google Scholar

5. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012; (63): 233–46.10.1146/annurev-med-041610-134208Search in Google Scholar

6. Feldmann J, Le Deist F, Ouachée–Chardin M et al. Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis. Br J Haematol. 2002; 117(4): 965–72.10.1046/j.1365-2141.2002.03534.xSearch in Google Scholar

7. Feldmann J, Callebaut I, Raposo G et al. Munc 13–4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003; 115(4): 461–73.10.1016/S0092-8674(03)00855-9Search in Google Scholar

8. Ohadi M, Lalloz MR, Sham P et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am J Hum Genet. 1999; 64(1): 165–71.10.1086/302187Search in Google Scholar

9. Dufourcq–Lagelouse R, Jabado N, Le Deist F et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21–22 and evidence for heterogeneity. Am J Hum Genet. 1999 Jan; 64(1): 172–9.10.1086/302194Search in Google Scholar

10. Stepp SE, Dufourcq–Lagelouse R, Le Deist F et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999; 286(5446): 1957–9.10.1126/science.286.5446.1957Search in Google Scholar

11. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002; 99(1): 61–610.1182/blood.V99.1.61Search in Google Scholar

12. Ansuini V, Rigante D, Esposito S. Debate around infection–dependent hemophagocytic syndrome in pediatrics. BMC Infect Dis. 2013; (13): 13–15.10.1186/1471-2334-13-15Search in Google Scholar

13. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis. 2000; 6(6): 601–8.10.3201/eid0606.000608Search in Google Scholar

14. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection– and malignancy–associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998; 12(2): 435–44.10.1016/S0889-8588(05)70521-9Search in Google Scholar

15. Danish EH, Dahms BB, Kumar ML. Cytomegalovirus– associated hemophagocytic syndrome. Pediatrics. 1985; 75(2): 280-3.10.1542/peds.75.2.280Search in Google Scholar

16. Bhatia S, Bauer F, Bilgrami SA. Candidiasis–associated hemophagocytic lymphohistiocytosis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 2003; 37(11): 161–6.10.1086/379615Search in Google Scholar

17. Watanabe T, Okazaki E, Shibuya H. Influenza A virus– associated encephalopathy with haemophagocytic syndrome. Eur J Pediatr. 2003; 162(11): 799–800.10.1007/s00431-003-1288-6Search in Google Scholar

18. Kaya Z, Oztürk G, Gürsel T, Bozdayi G. Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with Parvovirus B19 infection in a previously healthy child. Jpn J Infect Dis. 2005; 58(3): 149–51.Search in Google Scholar

19. Tuon FF, Gomes VS et al. Hemophagocytic syndrome associated with hepatitis A: case report and literature review. Rev Inst Med Trop Sao Paulo. 2008; 50(2): 123–7.10.1590/S0036-46652008000200012Search in Google Scholar

20. Brastianos PK, Swanson JW, Torbenson M, Sperati J, Karakousis PC. Tuberculosis–associated haemophagocytic syndrome. Lancet Infect Dis. 2006; 6(7): 447–54.10.1016/S1473-3099(06)70524-2Search in Google Scholar

21. Cascio A, Giordano S, Dones P, Venezia S, Iaria C, Ziino O. Haemophagocytic syndrome and rickettsial diseases. J Med Microbiol. 2011; 60(Pt 4): 537–42.10.1099/jmm.0.025833-021163825Search in Google Scholar

22. Gosh JB, Roy M, Bala A. Infection associated with Hemophagocytic Lymphohistiocytosis triggered by nosocomial infection. Oman Med J. 2009; 24(3): 223–5.Search in Google Scholar

23. Cascio A, Pernice LM et al. Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. Eur Rev Med Pharmacol Sci. 2012; 16(10): 1324–37.Search in Google Scholar

24. Gagnaire MH, Galambrun C, Stéphan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children – a series of 12 cases. Pediatrics. 2000; 106(4): E58.10.1542/peds.106.4.e5811015553Search in Google Scholar

25. Onishi R, Namiuchi S. Hemophagocytic syndrome in a patient with rheumatoid arthritis. Intern Med. 1994; 33(10): 607–11.10.2169/internalmedicine.33.6077827376Search in Google Scholar

26. Wong KF, Hui PK, Chan JK, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991; 114(5): 387–90.10.7326/0003-4819-114-5-3871992881Search in Google Scholar

27. Henter JI, Horhe A, Arico M et al. HLH–2004: Diagnostic an therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Pediatr Blood Cancer. 2007; 48(2): 124–31.10.1002/pbc.2103916937360Search in Google Scholar

28. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991; 18(1): 29–33.Search in Google Scholar

29. Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013; 139(6):713–27.10.1309/AJCP4ZDKJ4ICOUAT23690113Search in Google Scholar

30. Tang YM, Xu XJ. Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment. Scientific World Journal. 2011; 11: 697–708.10.1100/tsw.2011.62572005921442147Search in Google Scholar

31. Konuş OL, Ozdemir A, Akkaya A, Erbaş G, Celik H, Işik S. Normal liver, spleen and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am J Roentgenol. 1998; 171(6): 1693–8.10.2214/ajr.171.6.98433159843315Search in Google Scholar

32. Rademacher C, Hartmann D, Spiethoff A, Jakobs R. Ferritin and soluble interleukin–2–receptor in the diagnosis of fever of unknown origin. Dtsch Med Wochenschr. 2014; 139(1-2): 23–7.10.1055/s-0033-135992324390846Search in Google Scholar

33. Lehmberg K, McClain KL, Janka GE, Allen CE. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2014 Apr 21. [Epub ahead of print] PubMed PMID: 24753034.10.1002/pbc.2505824753034Search in Google Scholar

34. Imashuku S, Hibi S et al. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 1995; 86(12): 4706–7.10.1182/blood.V86.12.4706.bloodjournal86124706Search in Google Scholar

35. Wang LL, Hu YX, Chen WF et al. Significance of soluble interleukin-2 receptor and NK cell activity in patients with hemophagocytic lymphohistiocytosis. Zhongguo Shi Yan Xue Ye XueZaZhi. 2012; 20(2): 401–4.Search in Google Scholar

36. Sloma I, Vincent H, Addebbous A, Rivoisy C, Turhan GA, Michot JM. Haemophagocytic histiocyte in a peripheral blood film. Br J Haematol. 2014; 165(2): 163.10.1111/bjh.1269724372340Search in Google Scholar

37. Jabado N, McCusker C, BasileGde S. Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge. Allergy Asthma Clin Immunol. 2005; 1(4): 142–60.Search in Google Scholar

38. Kobayashi S, Ito M, Sano H et al. Clinical analysis of combination therapy for febrile neutropenic patients in childhood cancer. Pediatr Int. 2013; 55(1): 65–71.10.1111/ped.1202523240936Search in Google Scholar

39. Raghavendra M, Hoeg RT, Bottner WA, Agger WA. Management of neutropenic fever during a transition from traditional hematology/oncology service to hospitalist care. WMJ. 2014; 113(2): 53–8.Search in Google Scholar

40. Hung KC, Chiu HH, Tseng YC et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. J Microbiol Immunol Infect. 2003; 36(4): 254–9.Search in Google Scholar

41. Biondi E, McCulloh R, Alverson B, Klein A, Dixon A, Ralston S. Treatment of Mycoplasma Pneumonia: A Systematic Review. Pediatrics. 2014; 133(6):1081–90.10.1542/peds.2013-3729Search in Google Scholar

42. Aytaç S, Yildirim I, Ceyhan M et al. Risks and outcome of fungal infection in neutropenic children with hematologic diseases. Turk J Pediatr. 2010; 52(2): 121–5.Search in Google Scholar

43. Rajajee S, Ashok I, Manwani N, Rajkumar J, Gowrishankar K, Subbiah E. Profile of Hemophagocytic Lymphohistiocytosis; Efficacy of Intravenous Immunoglobulin Therapy. Indian J Pediatr. 2014 May 9. [Epub ahead of print] PubMed PMID: 24806152.10.1007/s12098-014-1461-0Search in Google Scholar

44. Scott R, Robb-Smith A. Histiocytic medullary reticulosis. Lancet. 1939; (2): 194–8.10.1016/S0140-6736(00)61951-7Search in Google Scholar

45. Farquhar J, Claireaux A. Familial haemophagocytic reticulosis. Arch Dis Child. 1952; 27(136): 519–525.10.1136/adc.27.136.519198856313008468Search in Google Scholar

46. Boake WC; Card WH, Kimmey JF. Histiocytic Medullary Reticulosis, Concurrence in Father and Son. Arch Intern Med. 1965; 116(2): 245–52.10.1001/archinte.1965.0387002008501614315657Search in Google Scholar

47. Henter JI, Ehrnst A, Andersson J, Elinder G. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr. 1993; 82(4): 369–372.10.1111/j.1651-2227.1993.tb12699.x8391350Search in Google Scholar

48. Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatr Blood Cancer. 2014; 61(7): 1329–35.10.1002/pbc.2501724610771Search in Google Scholar

49. Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013; 2013: 605–11.10.1182/asheducation-2013.1.60524319239Search in Google Scholar

50. Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis and treatment. J Pediatr. 2013; 163(5): 1253–9.10.1016/j.jpeds.2013.06.05323953723Search in Google Scholar

51. Balwierz W, Czogała M, Pawińska–Wasikowska K, Cwiklińska M, Walicka–Soja K. Hemophagocytic lymphohistiocytosis: diagnostic problems in pediatrics. Przegl Lek. 2010; 67(6): 417–24.Search in Google Scholar

52. Real E, Gomez A, Alcaraz MJ, Saez AI, Pastor E, Grau E. Fulminant hemophagocytic syndrome as presenting feature of T–cell lymphoma and Epstein–Barr virus infection. Haematologica. 2000; 85(4): 439–40.Search in Google Scholar

53. Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013; 161(5): 609–22.10.1111/bjh.1229323577835Search in Google Scholar

54. Guo X, Li Q, Zhou CY, Zhao YN. Clinical analysis of Epstein–Barr virus–associated hemophagocytic syndrome in children. Zhongguo Shi Yan Xue Ye XueZa-Zhi. 2013; 21(2): 460–4.Search in Google Scholar

55. Liapis K, Apostolidis J, Delimpasis S. EBV–associated hemophagocytic syndrome. Am J Hematol. 2011; 86(5): 422.10.1002/ajh.21811Search in Google Scholar

56. Henter JI, Nennesmo I. Neuropathologic findings and neurologic symptoms in twenty–three children with hemophagocytic lymphohistiocytosis. J Pediatr. 1997; 130(3): 358–65.10.1016/S0022-3476(97)70196-3Search in Google Scholar

57. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood. 1997; 89(3): 794–800.10.1182/blood.V89.3.794Search in Google Scholar

58. Janković G. Aplastic anemia. In: D. Manojlovic. Internal Medicine, 5th ed. Belgrade: The Institute for Textbooks, 2009; 1019–21.Search in Google Scholar

59. Čolović M. Leucemias. In: D. Manojlovic. Internal Medicine, 5th ed. Belgrade: The Institute for Textbooks, 2009; 1031–43.Search in Google Scholar

60. Aulbert E, Fromm H, Hornemann H. Ferritin in acute leukemia. Serum ferritin concentration as a nonspecific tumor marker for M1 and M2 myeloid leukemia. Med Klin (Munich). 1991; 86(6): 297–304.Search in Google Scholar

61. Huang SC, Chen JS, Cheng CN, Yang YJ. Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein–Barr virus– associated infectious mononucleosis. Eur J Haematol. 2012; 89(5): 417–22.10.1111/ejh.1200622897479Search in Google Scholar

62. Eid A, Keddissi JI, Kinasewitz GT. Hypoalbuminemia as a cause of pleural effusions. Chest 1999; 115(4): 1066-9.10.1378/chest.115.4.106610208209Search in Google Scholar

63. Tutor JD. Chylothorax in infants and children. Pediatrics. 2014; 133(4):722–33.10.1542/peds.2013-207224685960Search in Google Scholar

64. Popović G. Pleural effusions: a special review of pleural effusions in extrapulmonary disease. Pneumon 2010; 47(1-2): 73–80.Search in Google Scholar

65. Kogawa K, Sato H, Asano T et al. Prognostic factors of Epstein–Barr virus–associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014; 61(7): 1257–62.10.1002/pbc.2498024535916Search in Google Scholar

66. Ishii E, Ohga S et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007; 86(1): 58–65.10.1532/IJH97.0701217675268Search in Google Scholar

67. Chen CJ, Huang YC et al. Hemophagocytic syndrome: a review of 18 pediatric cases. J Microbiol Immunol Infect. 2004; 37(3): 157–63.Search in Google Scholar

68. Bakhshi S, Pautu JL. EBV associated hemophagocytic lymphohistiocytosis with spontaneous regression. Indian Pediatr. 2005; 42(12): 1253–5.Search in Google Scholar

69. Imashuku S. Treatment of Epstein–Barr virus–related hemophagocytic lymphohistiocytosis (EBV–HLH); update 2010. J Pediatr Hematol Oncol. 2011; 33(1): 35–9.10.1097/MPH.0b013e3181f84a5221088619Search in Google Scholar

70. Marsh RA, Jordan MB, Filipovich AH. Reduced–intensity conditioning haematopoetic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward. Br J Haematol. 2011; 154(5): 556–63.10.1111/j.1365-2141.2011.08785.x315566821707584Search in Google Scholar

71. Shiraishi A, Ohga S, Doi T et al. Treatment choice of immunotherapy or further chemotherapy for Epstein–Barr virus–associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2012; 59(2): 265–70.10.1002/pbc.2403922183955Search in Google Scholar

72. Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus–associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2007; 29(8): 569–73.10.1097/MPH.0b013e3180f61be317762500Search in Google Scholar